Natural Gas Investment Strategies: Futures vs. Producers
Money

Natural Gas Investment Strategies: Futures vs. Producers

authorBy JL Collins
DateJul 14, 2026
Read Time3 min

Investing in natural gas presents a crucial choice between two primary strategies: direct exposure through futures contracts via instruments like the United States Natural Gas Fund (UNG) or indirect investment in the companies that extract and produce natural gas, represented by funds such as the First Trust Natural Gas ETF (FCG). Despite a growing global demand for liquefied natural gas (LNG), investors in UNG have experienced significant declines in value over recent years. This contrasts sharply with the impressive gains achieved by FCG, which capitalizes on the same underlying demand thesis but through a different structural approach. The disparity in performance underscores the importance of understanding the mechanics of each investment type and aligning them with one's investment objectives and time horizon.

The United States Natural Gas Fund (UNG) is designed to track the spot price of Henry Hub natural gas by holding front-month futures contracts. However, this structure inherently exposes investors to a phenomenon known as 'contango,' where futures contracts for later months are priced higher than those for the nearer months. As UNG continuously rolls its positions from expiring contracts to new ones, it effectively sells lower-priced contracts and buys higher-priced ones, leading to a persistent drag on its performance. This structural flaw, coupled with an expense ratio of 1.24% and the complexities of K-1 tax forms, has resulted in substantial losses for UNG holders, with the fund declining over 77% in five years and over 91% in ten years, even when the underlying spot gas prices have remained relatively stable or trended sideways.

In stark contrast, the First Trust Natural Gas ETF (FCG) focuses on investing directly in natural gas production companies. This approach allows investors to benefit from the operational revenue and growth of these companies. Producers generate cash flow from every unit of natural gas sold, meaning they profit from increasing production volumes as much as from rising prices. Projections from the EIA indicate a significant increase in U.S. LNG exports, expected to reach 27.7 billion cubic feet per day (Bcf/d) by 2030. This expansion in export capacity directly translates into higher production volumes for these companies, boosting their revenues irrespective of minor fluctuations in Henry Hub prices. Consequently, FCG has delivered impressive returns, gaining nearly 17% year-to-date and almost 100% over the past five years, demonstrating how equity-based natural gas investments can effectively capture the burgeoning LNG demand.

While FCG offers a compelling avenue for long-term investors banking on the growth of LNG demand, it is important to acknowledge that it is not a pure commodity proxy. Its performance is also influenced by broader equity market movements and the energy sector's overall health. This means FCG carries equity-market beta, making it susceptible to widespread market downturns. For those seeking to hedge against specific short-term price spikes, UNG's front-month exposure might still serve its purpose, as demonstrated by previous volatile price movements triggered by supply shocks. However, for investors with a multi-year outlook focused on the fundamental expansion of natural gas production and export capabilities, an equity-based strategy like FCG appears to be the more suitable and rewarding choice.

The fundamental distinction between investing in natural gas futures and natural gas producers lies in their structural exposure to the market. Futures-based ETFs like UNG are plagued by contango and other overheads, making them less ideal for long-term holds despite tracking the commodity directly. Conversely, producer-focused ETFs like FCG leverage the growth in LNG export volumes and operational revenue, offering a more robust investment for capturing the long-term demand thesis. Therefore, investors should carefully evaluate their investment horizon and risk tolerance to select the strategy that best aligns with their financial objectives in the evolving natural gas landscape.

More Articles
Money
Federal Reserve's Unwavering Commitment to 2% Inflation Target
Federal Reserve Chairman Kevin Warsh reaffirmed the central bank's dedication to achieving a 2% inflation target during his testimony before House lawmakers. Despite recent data showing a cooling of inflation in June, Warsh stressed that the Fed will maintain its stringent stance to ensure price stability, asserting that a single month's data does not signify a complete victory over inflation. His remarks highlight the Fed's cautious approach to monetary policy, suggesting that higher interest rates may persist as they navigate economic conditions and political pressures.
By Natalie PaceJul 14, 2026
Money
TeraWulf Plans Multi-Billion Dollar Financing for Kentucky Data Center
TeraWulf Inc. (NASDAQ:WULF) is seeking to raise $3.5 billion in debt, including a leveraged loan, to fund a new data center campus in Kentucky. This significant financial endeavor, led by Morgan Stanley, is expected to generate an impressive $19 billion in revenue over a two-decade lease with Anthropic. Analysts have responded positively, increasing price targets for WULF shares, highlighting the company's strategic growth in digital infrastructure.
By Natalie PaceJul 14, 2026
Money
BofA Reinitiates Figma Coverage with 'Buy' Rating, Citing AI as a Catalyst
Bank of America has reinstated its coverage of Figma with a 'Buy' rating and a $30 price target. Analyst Tal Liani believes that concerns over generative AI's disruptive potential are overstated, viewing AI as a positive catalyst rather than a threat to the design software company's value. This positive outlook follows a significant decline in Figma's stock price, suggesting a potential rebound driven by AI integration.
By Ramit SethiJul 14, 2026
Money
Edwards Lifesciences Fined $10M for Antitrust Violations in JC Medical Acquisition
Edwards Lifesciences has been penalized $10 million for circumventing antitrust regulations during its acquisition of JC Medical. The Federal Trade Commission (FTC) alleged that Edwards intentionally structured the deal to avoid mandatory review, thereby delaying regulatory oversight. This penalty, along with an additional $2 million levied against JC Medical, marks the largest ever for failing to file under the Hart-Scott-Rodino Act. The ruling mandates Edwards to implement a robust antitrust compliance program.
By Chika UwazieJul 14, 2026
Money
AI Data Centers Spark Veteran Recruitment Amidst Tech Boom
As major tech companies invest billions in AI data centers, a significant labor shortage has emerged. This article explores how military veterans are being recruited and trained to fill these critical 'new-collar' roles, leveraging their transferable skills and addressing the growing demand for specialized talent in the rapidly evolving AI infrastructure landscape.
By Scott PapeJul 14, 2026